PNC FINANCIAL SERVICES GROUP, INC. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$410,000
+14.8%
100,0000.0%0.00%
Q4 2021$357,000
-1.9%
100,0000.0%0.00%
Q3 2021$364,000
-16.5%
100,0000.0%0.00%
Q2 2021$436,000
+6.1%
100,0000.0%0.00%
Q1 2021$411,000
+3.0%
100,0000.0%0.00%
Q4 2020$399,000
+47.8%
100,0000.0%0.00%
Q3 2020$270,000
-1.8%
100,0000.0%0.00%
Q2 2020$275,000
+16.5%
100,0000.0%0.00%
Q1 2020$236,000
-49.9%
100,000
-0.3%
0.00%
Q4 2019$471,000
+10.6%
100,262
-21.1%
0.00%
Q3 2019$426,000
-12.9%
127,086
-14.5%
0.00%
Q2 2019$489,000
+1.7%
148,656
-6.3%
0.00%
Q1 2019$481,000
-20.4%
158,594
-28.6%
0.00%
-100.0%
Q4 2018$604,000
+79.8%
222,039
+122.0%
0.00%
Q3 2018$336,000
+30.2%
100,0000.0%0.00%
Q2 2018$258,000
+17.3%
100,0000.0%0.00%
Q1 2018$220,000
+10.6%
100,0000.0%0.00%
Q4 2017$199,000
-38.6%
100,0000.0%0.00%
Q3 2017$324,000
+0.6%
100,0000.0%0.00%
Q2 2017$322,000
+13.4%
100,0000.0%0.00%
Q1 2017$284,000
+21.9%
100,0000.0%0.00%
Q4 2016$233,000
+23200.0%
100,000
+14714.8%
0.00%
Q2 2016$1,0000.0%675
-3.8%
0.00%
Q1 2016$1,0000.0%702
+3.5%
0.00%
Q4 2015$1,000
-80.0%
678
-74.7%
0.00%
Q3 2015$5,0000.0%2,678
+0.9%
0.00%
Q2 2015$5,000
-28.6%
2,655
+11.7%
0.00%
Q1 2015$7,0000.0%2,3760.0%0.00%
Q4 2014$7,0000.0%2,376
-29.6%
0.00%
Q3 2014$7,000
-87.5%
3,376
-83.6%
0.00%
Q2 2014$56,000
-23.3%
20,5760.0%0.00%
Q1 2014$73,000
-42.1%
20,576
-27.0%
0.00%
Q4 2013$126,000
+18.9%
28,200
+7.6%
0.00%
Q3 2013$106,000
+71.0%
26,200
+74.7%
0.00%
Q2 2013$62,00015,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders